About the Authors
- Oleg Chertov
-
Affiliation Protein Chemistry Laboratory, Advanced Technology Program, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland, United States of America
- Ning Zhang
-
Affiliation Laboratory of Molecular Immunoregulation, National Cancer Institute at Frederick, Frederick, Maryland, United States of America
- Xin Chen
-
Affiliation Laboratory of Molecular Immunoregulation, National Cancer Institute at Frederick, Frederick, Maryland, United States of America
- Joost J. Oppenheim
-
Affiliation Laboratory of Molecular Immunoregulation, National Cancer Institute at Frederick, Frederick, Maryland, United States of America
- Jacek Lubkowski
-
Affiliation Macromolecular Crystallography Laboratory, National Cancer Institute at Frederick, Frederick, Maryland, United States of America
- Connor McGrath
-
Affiliation Target Structure-Based Drug Discovery Group, Frederick, Maryland, United States of America
- Raymond C. Sowder II
-
Affiliation AIDS and Cancer Virus Program, SAIC-Frederick, Inc., Frederick, Maryland, United States of America
- Bruce J. Crise
-
Affiliation AIDS and Cancer Virus Program, SAIC-Frederick, Inc., Frederick, Maryland, United States of America
- Anatoli Malyguine
-
Affiliation Clinical Services Program, SAIC-Frederick, Inc., Frederick, Maryland, United States of America
- Michele A. Kutzler
-
Affiliation Department of Pharmacology, Fels Institute for Cancer Research and Molecular Biology, Center for Substance Abuse Research, Temple University School of Medicine, Philadelphia, Pennsylvania, United States of America
- Amber D. Steele
-
Affiliation Department of Pharmacology, Fels Institute for Cancer Research and Molecular Biology, Center for Substance Abuse Research, Temple University School of Medicine, Philadelphia, Pennsylvania, United States of America
- Earl E. Henderson
-
Affiliation Department of Pharmacology, Fels Institute for Cancer Research and Molecular Biology, Center for Substance Abuse Research, Temple University School of Medicine, Philadelphia, Pennsylvania, United States of America
- Thomas J. Rogers
-
* E-mail: rogerst@temple.edu
Affiliation Department of Pharmacology, Fels Institute for Cancer Research and Molecular Biology, Center for Substance Abuse Research, Temple University School of Medicine, Philadelphia, Pennsylvania, United States of America
Competing Interests
Several of the authors are employed by the National Institutes of Health (NIH), and the NIH was a sponsor of the research work. This does not alter the authors' adherence to all of the PLoS ONE policies on sharing of data and materials.
Author Contributions
Conceived and designed the experiments: OC JO EH TJR. Performed the experiments: OC NZ XC JL CM MAK AS TJR. Analyzed the data: OC JL CM RSI BC AM TJR. Contributed reagents/materials/analysis tools: OC JL CM RSI TJR. Wrote the paper: OC TJR.